Tomorrow, I’m entering a position in Pfizer Inc. (NYSE: PFE)—a globally recognized pharmaceutical giant with strong fundamentals and an attractive technical setup.
Pfizer maintains a solid revenue base, reporting $62.46 billion in total revenue in the last fiscal year. Despite recent fluctuations, its profitability remains intact, with a gross profit of $45.15 billion. The company continues to invest in drug innovation and strategic acquisitions, ensuring long-term growth.
Pfizer is a consistent dividend payer, making it an attractive choice for income-focused investors. Its dividend yield remains competitive, reinforcing its appeal as a long-term hold.
I see strong upside potential — both technically and fundamentally. Now is the perfect time to enter.
Trade active
I bought 200 shares today (225 total) and I bought 10 options!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.